KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,809,502 | +490.3% | 347,800 | +657.1% | 0.17% | +473.3% |
| Q2 2023 | $9,962,067 | -90.3% | 45,940 | -91.8% | 0.03% | -90.5% |
| Q1 2023 | $102,353,777 | +576.5% | 563,498 | +631.9% | 0.32% | +521.6% |
| Q4 2022 | $15,128,928 | -74.9% | 76,992 | -71.3% | 0.05% | -78.8% |
| Q3 2022 | $60,304,000 | +148.0% | 268,100 | +39.8% | 0.24% | +148.5% |
| Q1 2022 | $24,318,000 | +99.4% | 191,800 | +106.0% | 0.10% | +98.0% |
| Q4 2021 | $12,196,000 | +1879.9% | 93,097 | +146.7% | 0.05% | +1125.0% |
| Q3 2019 | $616,000 | – | 37,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |